OncoGenex Pharmaceuticals, Inc. (OGXI)
NASDAQ:OGXI Add to watch list

BioDueDiligence
Watch for update on NSCLC trial at $OGXI 4q11 CC - if $TEVA cans this trial, they can then terminate the whole 011 deal w/ 3 months notice

Feb. 7 at 3:24 PM

from Twitter
StockOsaurus
$OGXI coming to life

Feb. 6 at 12:12 PM
abubnic
Presenting @ BioCEO/Investor Conf. (Feb 13/14): $PATH $OMER $OGXI $ONCS $ONTY $OPXA $ORNI $OREX $OXGN $PTN $PDLI $PYC $PYMX $PSDV $ORX $RGEN

Feb. 3 at 10:21 AM
BiotechStockRsr
Clusterin now up a #GU12. OGX-11 $OGXI Yu gives prop to Phase I design. Now in two P3 trials

Feb. 2 at 2:04 PM

from Twitter
BioDueDiligence
$OGXI webcast re prostate and bladder cancer #ASCOGU data is at 635pm pacific tonight ....thanks guys

Feb. 2 at 8:17 AM

from Twitter
BioDueDiligence
$OGXI PRs on bladder http://t.co/JFzdIG3s and prostate http://t.co/BAHFIdEU HSP27 antisense at #ASCOGU - webcast today. $ISIS

Feb. 2 at 8:13 AM

from Twitter
BioDueDiligence
$OGXI ASCO GU data in prostate and bladder cancer seem ok but nothing to get excited about. agree?

Jan. 31 at 9:32 PM

from Twitter
ChimeraResearch
Heads up #ASCOGU12 Abstracts to be released tonight at 6pm - $MDVN $OGXI $AMGN #Bayer $PFE - https://t.co/cQENQdEC

Jan. 31 at 1:16 PM

from Twitter
abubnic
Presenting @ BioCEO/Investor Conf. (Feb 13/14): $PATH $OMER $OGXI $ONCS $ONTY $OPXA $ORNI $OREX $OXGN $PTN $PDLI $PYC $PYMX $PSDV $ORX $RGEN

Jan. 26 at 12:10 PM
ChimeraResearch
Preview of ASCO 2012 GU Symposium $MDVN $AMGN $OGXI $PFE Bayer - https://t.co/cQENQdEC

Jan. 19 at 1:26 AM

from Twitter
BioDueDiligence
Sorry, forgot to hit publish on this post - $OGXI 3q11 CC notes including comments on $EVEL debacle, $MDVN drug, etc: http://t.co/q4eccqMP

Dec. 12 at 3:54 PM

from Twitter
BioDueDiligence
$OGXI (w/ $TEVA and $ISIS) have separate pain and OS prostate cancer trials each w/ SPA because FDA required it. Full notes soon. $EXEL

Nov. 5 at 11:13 AM

from Twitter
BioDueDiligence
$OGXI (w/ $TEVA and $ISIS) have separate pain and OS prostate cancer trials each with SPA because that is what FDA required. Full notes soon

Nov. 5 at 11:08 AM

from Twitter
BioDueDiligence
$OGXI made it clear on 3q11 CC that they were not surprised by FDA response to $EXEL pain trial plan. Contrasting phase 3 programs (cont)

Nov. 5 at 11:07 AM

from Twitter
BioDueDiligence
3q11 #biotech earnings this week: $ASTX $ALNY $OPTR $SNTA $OGXI next week: $ISIS $MNTA $INFI $LGND $AIS notes & links: http://t.co/YJy5MkUo

Nov. 1 at 10:05 AM

from Twitter
BioDueDiligence
Follow $ADLR $ALNY $AIS $ASTX $BPAX $INFI $ISIS $LGND $MNTA $MYRX $OGXI $SNMX $SPPI $SNTA $TKMR ? Sign up for updates: http://t.co/SevtgPB8

Oct. 29 at 6:00 PM

from Twitter

Follow OGXI on StockTwits!

Join StockTwits and follow your favorite tickers. Get a personalized stream of news, charts, and ideas.

14.48 -0.89 (-5.79%) last updated 4:00 PM EST Feb 09

Follow 10 Followers

Chart Type: Daily | Weekly | Monthly

Price
Fund

OGXI Related Tickers

Company	Msg Trend	Last Price
$BPAX BioSante Pharmaceu...	+	0.90 +0.06 (7.14%)
$AEZS AEterna Zentaris I...	N/C	1.70 -0.05 (-2.86%)
$INO Inovio Pharmaceuti...	+	0.66 -0.03 (-4.35%)
$ARQL ArQule Inc.	N/C	7.87 -0.03 (-0.38%)
$HEB Hemispherx Biophar...	N/C	0.33 -0.01 (-2.94%)

Prev 1 2 Next

OncoGenex Pharmaceuticals, Inc. (OGXI)
NASDAQ:OGXI Add to watch list

Follow OGXI on StockTwits!

OGXI Related Tickers

OGXI on Yahoo! Finance

OGXI Chart.ly Charts

OncoGenex Pharmaceuticals, Inc. (OGXI) NASDAQ:OGXI Add to watch list

Follow OGXI on StockTwits!

OGXI Related Tickers

OGXI on Yahoo! Finance

OGXI Chart.ly Charts

Sign in to StockTwits X

New to StockTwits?

Sign up for real time news, charts, and ideas on the stocks you care about.

OncoGenex Pharmaceuticals, Inc. (OGXI)
NASDAQ:OGXI Add to watch list